Outcomes of surveillance VS. adjuvant chemotherapy for patients with STAGE IA and IB NON-seminomatous testicular germ-cell tumors.

Bilici, AhmetGumus, MahmutOdabas, HaticeKandemir, NurtenDemirci, UmutCihan, SenerBayoglu, Ibrahim Vedat2024-06-122024-06-1220160732-183X1527-7755https://doi.org/10.1200/JCO.2016.34.15_suppl.e16051https://hdl.handle.net/20.500.14551/25931Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- JUN 03-07, 2016 -- Chicago, IL[Abstract Not Available]en10.1200/JCO.2016.34.15_suppl.e16051info:eu-repo/semantics/closedAccess[No Keywords]Outcomes of surveillance VS. adjuvant chemotherapy for patients with STAGE IA and IB NON-seminomatous testicular germ-cell tumors.Conference Object3415Q1WOS:000404711500029